20 . March , 2019 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Nefazodone Hydrochloride

Big Image Pronouncation: (neff-AZE-oh-dohn HIGH-droe-KLOR-ide)
Class: Antidepressant

Trade Names:
Nefazodone Hydrochloride
- Tablets 50 mg
- Tablets 100 mg
- Tablets 150 mg
- Tablets 200 mg
- Tablets 250 mg

Mechanism of Action


Undetermined; inhibits neuronal uptake of serotonin and norepinephrine; antagonizes alpha-1 adrenergic receptors.



Absorbtion is rapid and complete. Absolute bioavailability is approximately 20%, T max is about 1 hr, and steady state is 4 to 5 days (parent and metabolite). Food delays absorption and decreases bioavailability.


Nefazodone is widely distributed in body tissues, including CNS, and exhibits nonlinear kinetics for dose and time. Nefazodone Vd is 0.22 to 0.87 L/kg and plasma protein binding is more than 99%.


Nefazodone is extensively metabolized in the liver by n-dealkylation and aliphatic and aromatic hydroxylation. Three active metabolites are hydroxynefazodone (HO-NEF), meta-chlorophenylpiperazine (mCPP), and triazole-dione.


Nefazodone is eliminated in urine (less than 1% excreted as unchanged) and feces. The t ½ is 2 to 4 hr (parent compound), 1.5 to 4 hr (HO-NEF), 4 to 8 hr (mCPP), and 18 hr (triazole-dione).

Special Populations


C max and AUC for nefazodone and HO-NEF were twice as high. Initiate at half the dose, especially in elderly women.


Nefazodone has a higher C max and AUC in women in single dose, but no difference after multiple doses.

Liver Cirrhosis

AUC for nefazodone and HO-NEF at steady state were approximately 25% greater.

Indications and Usage

Treatment of depression.


Coadministration with carbamazepine, cisapride, or pimozide; hypersensitivity to nefazodone or other phenylpiperazine antidepressants (eg, trazodone).

Dosage and Administration


PO 100 mg bid initially; increase by 100 to 200 mg increments q wk (max, 600 mg/day).

Elderly and Debilitated Patients

PO 50 mg bid initially; increase by 100 mg increments q wk (max, 600 mg/day).

General Advice

  • Administer without regard to meals. Administer with food if GI upset occurs.


Store tablets at controlled room temperature (59° to 86°F).

Drug Interactions


Increased plasma concentrations and effects of alprazolam and triazolam.


Elevated buspirone concentrations and decreased buspirone metabolite plasma concentrations.


Elevated serum carbamazepine concentrations with possible increase in side effects may occur.


Increased cisapride plasma concentrations with cardiotoxicity may occur.


Increased plasma levels of digoxin.


Decreased haloperidol clearance; may need to adjust haloperidol dose.

HMG-CoA reductase inhibitors (eg, simvastatin)

The risk of rhabdomyolysis occurrence may be increased.


Do not use nefazodone concurrently or within 14 days of discontinuing an MAOI; do not start MAOIs within 1 wk of stopping nefazodone.


Increased plasma concentrations of pimozide may occur associated with QT prolongation and rare cases of serious cardiovascular adverse events, including death, principally caused by ventricular tachycardia of the torsades de pointes type.


Nefazodone may decrease propranolol serum concentration; propranolol may interfere with nefazodone metabolism.

St. John's wort

Increased sedative-hypnotic effects may occur.

Sibutramine, sumatriptan, trazodone

Serotonin syndrome, including irritability, increased muscle tone, shivering, myoclonus, and altered consciousness may occur.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Postural hypotension, vasodilation (4%); hypotension (2%); sinus bradycardia (1.5%).


Headache (36%); somnolence (28%); dizziness (22%); asthenia, insomnia (11%); lightheadedness (10%); confusion (8%); memory impairment, paresthesia (4%); abnormal dreams, decreased concentration (3%); ataxia, incoordination, psychomotor retardation, tremor (2%); hypertonia, decreased libido (1%); convulsions (postmarketing).


Pruritus, rash (2%); Stevens-Johnson syndrome (postmarketing).


Abnormal vision (10%); blurred vision (9%); pharyngitis (6%); tinnitus (3%); taste perversion, visual field defect (2%).


Dry mouth (25%); nausea (23%); constipation (17%); dyspepsia (9%); diarrhea (8%); increased appetite (5%); nausea and vomiting (2%); gastroenteritis (at least 1%).


Urinary frequency, UTI, urinary retention, vaginitis (2%); breast pain (1%); impotence (at least 1%); gynecomastia (male), priapism (postmarketing).


Thrombocytopenia (postmarketing).


Liver necrosis, liver failure (postmarketing).

Lab Tests

Decreased hematocrit (3%).


Peripheral edema (3%); thirst (1%); galactorrhea, hyponatremia, increased prolactin (postmarketing).


Arthralgia (1%).


Increased cough (3%); dyspnea, bronchitis (at least 1%).


Infection (8%); flu-like syndrome (3%); chills, fever (2%); neck rigidity (1%); anaphylactic reactions, angioedema, serotonin syndrome (postmarketing).



Life-threatening cases of hepatic failure have been reported. Counsel patient about and immediately report signs of liver dysfunction. Do not initiate therapy in patients with active liver disease or elevated baseline serum transaminases. There is no evidence that preexisting liver disease increases risk of liver failure, but it can complicate patient monitoring. Withdraw therapy and do not consider retreatment if serum AST or ALT is 3 times the upper limit of normal or more.


Category C .




Safety and efficacy not established.


Initiate treatment at half the usual dose. Dosage range same as younger patients.


Sinus bradycardia reported in 1.5% of patients; use with caution in patients with recent MI or unstable heart disease.


May activate mania/hypomania; use with caution in patients with history of mania.

Postural hypotension

Use with caution in patients with known cardiovascular or cerebrovascular disease that could be exacerbated by hypotension (eg, history of MI, angina, ischemic stroke) and conditions that would predispose to hypotension (eg, dehydration, hypovolemia, treatment with antihypertensive medications).


Priapism (eg, prolonged, painful, inappropriate penile erection) has been reported with closely related antidepressants. Discontinuation of therapy is necessary.


Rare cases of petit mal and grand mal seizures reported.


Closely monitor patients at risk, and do not give them access to excessive quantities.

Visual disturbances

Visual disturbances, including blurred vision, scotoma, and visual trails reported.



Nausea, vomiting, somnolence.

Patient Information

  • Advise patient to read the patient information leaflet before starting therapy and with each refill.
  • Advise patient that medication will be started at a low dose and then gradually increased as tolerated until max benefit is obtained.
  • Advise patient to take prescribed dose bid without regard to meals but to take with food if stomach upset occurs.
  • Advise patient that if a dose is missed to skip that dose and take the next dose at the regularly scheduled time. Caution patient to never take 2 doses at the same time.
  • Advise patient not to change the dose or stop taking unless advised by health care provider.
  • Inform patient that it may take 1 to 4 wk to note improvement in symptoms and to continue with the prescribed therapy once improvement has been noted.
  • Advise patient to take frequent sips of water, suck on ice chips or sugarless hard candy, or chew sugarless gum if dry mouth occurs.
  • Advise patient to avoid alcoholic beverages.
  • Advise patient that drug may cause drowsiness or impair judgment, thinking, or reflexes and to use caution while driving or performing other tasks requiring mental alertness until tolerance is determined.
  • Advise patient to immediately report any of the following to health care provider: nausea, vomiting, abdominal pain, fatigue, anorexia, dark urine, yellowing of the skin or eyes, seizure, or fainting.
  • Advise patient to contact health care provider if rash, hives, or other symptoms of an allergic reaction develop, if a painful or prolonged erection occurs, or if experiencing bothersome side effects such as visual disturbances, headache, insomnia, or drowsiness.

Recent Drug Updates at DrugIndexOnline:

Children's Dimetapp Decongestant Infant Drops Children's Dimetapp Decongestant Infant Drops
Generic Name: Pseudoephedrine Drops (soo-doe-e-FED-rin) Brand Name: Examples include Children's Dimetapp Decongestant Infant and PediaCare InfantChildren's Dimetapp Decongestant Infant Drops is used for:Relieving congestion due to colds, flu, and allergies. It may also be used for other conditi more...

clonidine and chlorthalidone clonidine and chlorthalidone
Generic Name: clonidine and chlorthalidone (KLOE ni deen and klor THAL i done) Brand Names: Clorpres, Combipres What is clonidine and chlorthalidone? Clonidine decreases the levels of certain hormones in your blood. This effect allows your blood vessels (veins and arteries) to relax and more...

Cordran Lotion Cordran Lotion
Generic Name: Flurandrenolide Lotion (flure-an-DREN-oh-lide) Brand Name: CordranCordran Lotion is used for:Treating inflammation and itching due to certain skin conditions. It may also be used for other conditions as determined by your doctor. Cordran Lotion is a topical adrenocortical steroid. more...

Focalin XR Focalin XR
Generic Name: dexmethylphenidate hydrochloride Dosage Form: Capsules, extended release T2007-22      Focalin® XR     CII           (dexmethylphenidate hydrochloride)    &n more...

Hemin Hemin
Generic Name: Hemin (HE-min) Brand Name: PanhematinHemin should only be used if other medicines are not tolerated or effective. Hemin is used for:Treating symptoms of certain blood disorders (porphyria). It may also be used for other conditions as determined by your doctor. Hemin is an enzyme more...

Plaquenil Plaquenil
Generic Name: hydroxychloroquine sulfate Dosage Form: Tablets, usp Warning PHYSICIANS SHOULD COMPLETELY FAMILIARIZE THEMSELVES WITH THE COMPLETE CONTENTS OF THIS LEAFLET BEFORE PRESCRIBING HYDROXYCHLOROQUINE. Plaquenil Description Hydroxychloroquine sulfate is a colorless crystalline solid, so more...

Poly Iron Poly Iron
Generic Name: iron polysaccharide (I ern paw lee SACK ah ride) Brand Names: Fe-Tinic 150, Hytinic, Niferex, Nu-Iron, Nu-Iron 150, Poly Iron What is Poly Iron (iron polysaccharide)? Iron polysaccharide is a form of the mineral iron. Iron is important for many functions in the body, espec more...

Promethazine injection Promethazine injection
Generic Name: promethazine hydrochloride Dosage Form: Injection, usp Rx only Promethazine Injection Description Promethazine HCl Injection, is a sterile, pyrogen-free solution for deep intramuscular or intravenous administration. Promethazine HCl (10H-Phenothiazine-10-ethanamine, N,N,α-tr more...